Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1115 | 1013 | 1274 | 1325 | 1568 | 1812 |
Fund Return | 11.48% | 1.28% | 27.41% | 9.84% | 9.41% | 6.12% |
Place in category | 30 | 34 | 12 | 3 | 7 | 13 |
% in Category | 7 | 12 | 4 | 1 | 3 | 4 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Brandes International Small Cap EqI | 575.53M | 23.34 | 15.01 | 7.85 | ||
Brandes Emerging Markets Value I | 477.66M | 7.71 | 3.53 | 1.70 | ||
Brandes Emerging Markets Value A | 161.23M | -5.07 | 0.44 | 1.13 | ||
Brandes International Small Cap Equ | 77.17M | -1.68 | 13.65 | 5.40 | ||
Brandes International Equity Fund A | 54.38M | -1.20 | 9.98 | 4.79 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Dodge & Cox International Stock | 39.84B | 8.75 | 5.16 | 4.54 | ||
Fidelity Series International VVV | 14.98B | 10.37 | 7.59 | 5.74 | ||
Vanguard International Value Inv | 13.97B | 4.98 | 2.27 | 4.43 | ||
Causeway International Value Instl | 10.35B | 6.85 | 8.13 | 5.56 | ||
DFA International Value I | 8.8B | 9.09 | 7.07 | 5.42 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Alibaba | KYG017191142 | 3.47 | 89.15 | -1.55% | |
Takeda Pharmaceutical | JP3463000004 | 2.89 | 4,224.0 | +0.55% | |
Sanofi | FR0000120578 | 2.59 | 94.04 | -0.73% | |
Heineken | NL0000008977 | 2.51 | 61.50 | -0.24% | |
UBS Group | CH0244767585 | 2.27 | 28.07 | -0.64% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Neutral | Buy |
Technical Indicators | Strong Sell | Sell | Strong Buy |
Summary | Strong Sell | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review